Furthermore, overexpression of βIVa-Tubulin (TUBB4) is correlated with the poor response of paclitaxel treatment in patients diagnosed with ovarian cancer and NSCLC (52, 53). The gene discussed is TUBB3; the disease is ovarian carcinoma.